Scientists dig into DNA to unlock retinoblastoma secrets
NCT ID NCT06725173
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the genes of 100 people with retinoblastoma, a rare eye cancer, to learn how changes in the RB1 gene cause the disease and related cancers. Participants give a blood or saliva sample for genetic testing. The goal is to better understand the link between a person's genes and their cancer, which may help improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Washington
RECRUITINGSeattle, Washington, 98109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Targeted radiation zaps childhood brain tumors in early trial
- Newborn screening study aims to catch rare diseases at birth
- Eye-Directed chemotherapy aims to save sight in children with retinoblastoma
- Does anesthesia affect kids' brains? new study investigates
- Chemo plaque could spare Kids' eyes from removal